Search All News
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
- October 2, 2020
New data mining techniques are uncovering previously hidden adverse drug effects that impact women more than men.
- July 6, 2020
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
- June 8, 2020
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
- May 15, 2020
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.
- March 24, 2020
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
- February 18, 2020
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
- August 30, 2019
CUIMC biologists developed a computer algorithm that uncovered previously unknown interactions between viruses and human proteins, providing new insights into Zika and HPV.
- August 20, 2019
Synthetic biologists at Columbia have created a technique that could prevent human-engineered proteins from spreading into the wild or mutating.